FOXO4-DRI — The Senolytic Peptide
FOXO4-DRI is one of the boldest ideas in aging research: a “senolytic” — a molecule studied for clearing out senescent cells, the worn-out “zombie” cells that build up with age and refuse to die. Its clever D-retro-inverso design makes it stable enough to do the job in research. Published batch documentation is shown on the COA page when a matching record is available.
Why review FOXO4-DRI with Aeternum Life
The listing identifies this item as a laboratory research material.
Identity, format, storage, and package information are shown on the product page.
Destination availability, dispatch details, and tracking are confirmed for the order.
COA records appear by product and batch when a matching record is published.
What is FOXO4-DRI?
FOXO4-DRI is a synthetic “senolytic” peptide built with a D-retro-inverso (DRI) design — a mirror-image construction that makes it far more stable. It’s engineered to interfere with a protein interaction (FOXO4 and p53) that keeps senescent cells alive.
Senescent cells — sometimes called “zombie cells” — stop dividing but don’t die, and they accumulate with age. FOXO4-DRI is one of the most studied tools in senolytic research, aimed at clearing them, and it’s typically studied in short pulse cycles. Aeternum Life supplies it as ultra-high-purity research material with a batch-specific Certificate of Analysis on every order.
The design of FOXO4-DRI is unusually literal. In senescent cells, FOXO4 binds p53 and holds it in the nucleus, blocking the apoptotic signal that would normally clear a damaged cell. FOXO4-DRI is a copy of the binding region built to compete for that interaction and release p53. The “DRI” is the engineering: a D-retro-inverso peptide reverses the sequence and uses D-amino acids, so the side chains still present in the same spatial arrangement while proteases — which recognise L-amino acids — no longer cleave it. That trick is why the molecule became the reference compound for the senolytic concept.
Research directions
FOXO4-DRI is a flagship of senolytic research. Here’s the focus.
The headline: FOXO4-DRI is studied for selectively clearing worn-out senescent cells.
It targets the FOXO4-p53 interaction that keeps senescent cells from dying.
Senescent-cell buildup is a core driver studied in cellular-aging research.
Clearing senescent cells is a headline strategy in modern longevity science.
It’s typically studied in short, intermittent pulses rather than continuously.
For research purposes only. These materials are not drugs or dietary supplements and are not intended to diagnose, treat, cure or prevent any disease.
Join the Aeternum Life community
Get research summaries, batch-record updates, restock alerts, and customer support. We do not provide dosing, reconstitution, or administration guidance.
Join our Telegram
FOXO4-DRI documentation
- Published product specification
- Reported purity and test date when available
- Batch number shown on matching records
- Laboratory and verification details only when supplied
The COA page shows the batch documentation currently published. Missing fields are left blank rather than inferred.
Handling & Storage
Guidance for handling FOXO4-DRI as a laboratory research material.
Store lyophilized FOXO4-DRI cold and protected from light, sealed and dry until use.
Handle FOXO4-DRI according to standard laboratory practice for research materials.
Published batch documentation is linked when a matching record is available.
FOXO4-DRI is supplied strictly for laboratory and research use. Not for human or veterinary consumption; no administration or dosing guidance is provided.
Specifications
- Name
- FOXO4-DRI
- Type
- Senolytic peptide (D-retro-inverso)
- Appearance
- White lyophilized powder
- Size
- 10 mg per vial
- Purity
- ≥ 99% (HPLC, see COA)
- Storage
- Store at 2–8°C, protect from light
For research use. Not intended to diagnose, treat, cure or prevent any disease.
Frequently asked questions
What does “D-retro-inverso” mean?
It is a stability technique. The amino-acid sequence is reversed and built from D-amino acids instead of the natural L form. The two inversions cancel out geometrically, so the side chains sit where they did in the original peptide, but proteases that only recognise L-amino acids can no longer break it down.
What is FOXO4-DRI studied for?
It’s studied as a senolytic — clearing senescent cells — around the FOXO4/p53 interaction and cellular aging. We share these as research directions, not medical claims.
How is it typically used in research?
FOXO4-DRI is usually studied in short, intermittent pulse cycles.
Is FOXO4-DRI for human use?
No. Aeternum Life supplies FOXO4-DRI strictly as a research-grade material for laboratory research. It is not sold for human or veterinary consumption.
Is a COA available for FOXO4-DRI?
Published COA records are available by product and batch when a matching record exists. Laboratory and verification details appear only when stated in that record.
About Aeternum Life
Aeternum Life Limited publishes clearly labeled laboratory research materials and accessories, with specifications and available batch documentation.
Keep up with the FOXO4-DRI research
New reviews, data and study summaries — sent when there is something worth reading, not on a schedule.
No spam. Unsubscribe anytime.
Questions before you order?
Message us on WhatsApp for pricing, bulk quotes, stock, shipping and order support — a real person, usually within a few hours.
Message us on WhatsAppExplore the full Aeternum Life range
FOXO4-DRI is part of the Aeternum Life research catalog. Review its intended-use status, specifications, and any currently published batch record before ordering.
Browse all products